Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases? - PubMed (original) (raw)

Review

Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases?

Hyoung-gon Lee et al. Brain Pathol. 2003 Oct.

Abstract

Protein aggregation and misfolding characterize most age-related neurodegenerative diseases including Alzheimer, Parkinson and Huntington diseases. Protein aggregation has generally been assumed to be responsible for neurodegeneration in these disorders due to association and genetics. However, protein aggregation may, in fact, be an attempt to protect neurons from the stress resulting from the disease etiology. In this review, we weigh the evidence of whether removal of amyloids, aggregates and neuronal inclusions represent a reasonable strategy for protecting neurons.

PubMed Disclaimer

Similar articles

• Protein precipitation: a common etiology in neurodegenerative disorders?
  Kakizuka A. Kakizuka A. Trends Genet. 1998 Oct;14(10):396-402. doi: 10.1016/s0168-9525(98)01559-5. Trends Genet. 1998. PMID: 9820028
• AQAMAN, a bisamidine-based inhibitor of toxic protein inclusions in neurons, ameliorates cytotoxicity in polyglutamine disease models.
  Hong H, Koon AC, Chen ZS, Wei Y, An Y, Li W, Lau MHY, Lau KF, Ngo JCK, Wong CH, Au-Yeung HY, Zimmerman SC, Chan HYE. Hong H, et al. J Biol Chem. 2019 Feb 22;294(8):2757-2770. doi: 10.1074/jbc.RA118.006307. Epub 2018 Dec 28. J Biol Chem. 2019. PMID: 30593503 Free PMC article.
• Protein misfolding and neurodegeneration.
  Soto C, Estrada LD. Soto C, et al. Arch Neurol. 2008 Feb;65(2):184-9. doi: 10.1001/archneurol.2007.56. Arch Neurol. 2008. PMID: 18268186 Review.
• Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?
  Muchowski PJ. Muchowski PJ. Neuron. 2002 Jul 3;35(1):9-12. doi: 10.1016/s0896-6273(02)00761-4. Neuron. 2002. PMID: 12123602 Review.
• Amyloid in neurodegenerative diseases: friend or foe?
  Wolfe KJ, Cyr DM. Wolfe KJ, et al. Semin Cell Dev Biol. 2011 Jul;22(5):476-81. doi: 10.1016/j.semcdb.2011.03.011. Epub 2011 Mar 31. Semin Cell Dev Biol. 2011. PMID: 21458579 Free PMC article. Review.

Cited by

• Proteasome activator enhances survival of Huntington's disease neuronal model cells.
  Seo H, Sonntag KC, Kim W, Cattaneo E, Isacson O. Seo H, et al. PLoS One. 2007 Feb 28;2(2):e238. doi: 10.1371/journal.pone.0000238. PLoS One. 2007. PMID: 17327906 Free PMC article.
• Intratumoral patterns of genomic imbalance in glioblastomas.
  Nobusawa S, Lachuer J, Wierinckx A, Kim YH, Huang J, Legras C, Kleihues P, Ohgaki H. Nobusawa S, et al. Brain Pathol. 2010 Sep;20(5):936-44. doi: 10.1111/j.1750-3639.2010.00395.x. Epub 2010 Mar 18. Brain Pathol. 2010. PMID: 20406234 Free PMC article.
• Mechanisms of neuronal death in synucleinopathy.
  Takeda A, Hasegawa T, Matsuzaki-Kobayashi M, Sugeno N, Kikuchi A, Itoyama Y, Furukawa K. Takeda A, et al. J Biomed Biotechnol. 2006;2006(3):19365. doi: 10.1155/JBB/2006/19365. J Biomed Biotechnol. 2006. PMID: 17047300 Free PMC article.
• Sequence determinants of protein aggregation: tools to increase protein solubility.
  Ventura S. Ventura S. Microb Cell Fact. 2005 Apr 22;4(1):11. doi: 10.1186/1475-2859-4-11. Microb Cell Fact. 2005. PMID: 15847694 Free PMC article.
• Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.
  Siedlak SL, Casadesus G, Webber KM, Pappolla MA, Atwood CS, Smith MA, Perry G. Siedlak SL, et al. Free Radic Res. 2009 Feb;43(2):156-64. doi: 10.1080/10715760802644694. Free Radic Res. 2009. PMID: 19160110 Free PMC article.

References

1. 1. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, Romano DM, Hartshorn MA, Tanzi RE, Bush AI (1998) Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273:12817–12826. - PubMed
2. 1. Atwood CS, Perry G, Smith MA (2003) Cerebral hemorrhage and amyloid‐beta. Science 299:1014. - PubMed
3. 1. Bates G (2003) Huntingtin aggregation and toxicity in Huntington's disease. Lancet 361:1642–1654. - PubMed
4. 1. Behl C, Davis J, Cole GM, Schubert D (1992) Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Commun 186:944–950. - PubMed
5. 1. Betarbet R, Sherer TB, MacKenzie G, Garcia‐Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301–1306. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Wiley

• Medical

  • MedlinePlus Health Information